16 results
DEF 14A
CMRA
Comera Life Sciences Holdings, Inc.
11 Aug 23
Definitive proxy
4:15pm
and commercializing antibiotics and combination therapies for the treatment of acute and chronic infections. Ms. McCourt’s prior biotechnology
PRE 14A
CMRA
Comera Life Sciences Holdings, Inc.
1 Aug 23
Preliminary proxy
5:08pm
., a biotechnology company focused on developing and commercializing antibiotics and combination therapies for the treatment of acute and chronic infections. Ms
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
, and is estimated to grow at an 8.8% CAGR through 2032. Global market growth is attributed to the ongoing rising prevalence of chronic and acute diseases … ., a biotechnology company focused on developing and commercializing antibiotics and combination therapies for the treatment of acute and chronic infections
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
of chronic and acute diseases as well as general aging of the population. Therapeutic proteins, including monoclonal antibodies, accounted for 66 … of acute and chronic infections. Ms. McCourt’s prior biotechnology and pharmaceutical experience also includes roles in business development, marketing
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:32pm
to grow at an 8.8% CAGR through 2032. Global market growth is attributed to the ongoing rising prevalence of chronic and acute diseases as well … ., a biotechnology company focused on developing and commercializing antibiotics and combination therapies for the treatment of acute and chronic infections. Ms
424B3
50u03rcyoqy
15 Sep 22
Prospectus supplement
4:09pm
424B3
5ntv4phqq4axk
28 Jun 22
Prospectus supplement
10:45am
S-1
zgqd 5rsjh029xka
4 May 22
IPO registration
9:23pm
424B3
1zf03p
15 Apr 22
Prospectus supplement
11:45am
S-4/A
6l3ob5lp5gp9ld 0edm3
25 Mar 22
Registration of securities issued in business combination transactions (amended)
5:17pm
S-4
qk4lu8gzaq1aqz5swlh
8 Mar 22
Registration of securities issued in business combination transactions
9:49pm
- Prev
- 1
- Next